The Scientist behind the COVID-19 mRNA vaccine says: “the next target is cancer”

Coronavirus vaccine technology will soon be used to fight cancer, according to the scientist who was awarded the prize for developing the first widely-used vaccine for the virus.

Together with her husband, Ugur Sahin, Ozlem Tureci founded the German company BioNTech. After discovering an unknown virus last year, they devoted themselves to studying how the body’s immune system can be used to combat tumors.

This led them to apply their 20 years of research into new threats.

Canada and the UK approved BioNTech’s mRNA vaccines within a week of each other in December.

Over a hundred additional nations have followed suit. More than 10 million people around the world have received a vaccine developed by Pfizer and given to them since that time.

Value of BioNTech increases as the pandemic continues, allowing the company to pursue its original goal of developing an anti-cancer tool with the funds it now has at its disposal.

It is the messenger RNA, or mRNA, that carries instructions into the human body for the production of proteins to combat specific viruses manufactured by BioNTech-Pfizer and American competitor Moderna.

Immune system attacks tumors using the same principles.

Several mRNA-based cancer vaccines are now available, according to Tureci.

Asked when these therapies might be available, Tureci said, “This is difficult to predict in the development of innovations.” However, we expect that our cancer vaccines will be available to the general public within a few years. Degree.”

It’s the goal of both Tureci and Sahin right now to make sure that any new virus mutations don’t affect the vaccine they’ve been working on.

The couple took time out of their busy schedules on Friday to accept Germany’s highest honor, the Medal of Honor, from President Frank-Walter Steinmeier.

The ceremony will be attended by German Chancellor Angela Merkel (Angela Merkel), who is a trained scientist.

It’s a great honor to receive this award, Tureci said.

The two of us, my husband and I, are in tears. In spite of this, she maintains that developing vaccines is the responsibility of a wide range of individuals. All of us at BioNTech and our partners, as well as the authorities in the government and the regulatory agencies have worked hard to make this happen. They’re all in it together, and there’s a real sense of urgency,” she explained. “We believe this is a celebration of scientific achievements and a recognition of such efforts.”

LEAVE A REPLY

Please enter your comment!
Please enter your name here